AVTR, US05352A1007

Bernstein keeps USD 15.50 target for Avantor stock

Published on 10/20/2026 at 20:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Avantor will report third-quarter results on October 28, 2026 before the open. Avantor stock costs EUR 14.91 on October 20, 2026.

Analyst target and reporting date

  • Bernstein maintained a Hold rating and set a USD 15.50 target on October 16, 2026.
  • Avantor will publish third-quarter 2026 results on October 28, 2026.
  • Avantor stock costs EUR 14.91 at Lang & Schwarz on October 20, 2026 at 8:49 p.m. CEST.
  • Second-quarter 2026 revenue was USD 1.69 billion, versus USD 1.68 billion a year earlier.
AVTR, US05352A1007, Illustration mit AI erstellt.

Avantor stock (ISIN US05352A1007) has a fresh analyst reference point ahead of its next report. Bernstein analyst Eve Burstein maintained a Hold rating and set a USD 15.50 price target on October 16, 2026, according to Markets Insider. At Lang & Schwarz, the stock was trading at EUR 14.91 on October 20, 2026 at 8:49 p.m. CEST.

Bernstein keeps a cautious target

Bernstein's USD 15.50 target was 7.79 percent below Avantor's USD 16.81 primary-market price at 2:55 p.m. EDT on October 20, 2026. The target therefore sat below the latest quoted level, while the Hold rating pointed to a measured view rather than a bullish revision. The target and rating were dated to the October 16 analyst note in the Markets Insider report.

October 28 brings results

Avantor is scheduled to release its third-quarter 2026 financial results before the market opens on October 28, 2026, with a conference call at 8:00 a.m. Eastern Time. The date was announced in an October 1, 2026 release on the company's investor-relations site, which also identifies Avantor as a NYSE-listed company.

The last reported quarter gives investors a measurable baseline. In the second quarter of 2026, revenue reached USD 1.69 billion versus USD 1.68 billion a year earlier, while net income fell to USD 38.10 million from USD 64.70 million, according to Markets Insider. That combination puts revenue near the prior-year level but leaves profit as the more demanding comparison.

What does the target imply?

The second-quarter operating margin was 7.00 percent, based on operating profit of USD 121.80 million and revenue of USD 1.69 billion. Adjusted earnings per share came to USD 0.21, up 10.53 percent from the USD 0.19 consensus estimate, while full-year adjusted earnings guidance was raised to USD 0.80-0.83 per share, according to Zacks.

Avantor versus life science peers

Avantor: price to earnings ratio -20.01, market capitalization USD 11.4 billion. Thermo Fisher Scientific (NYSE, USD): up 1.77 percent, price to earnings ratio 37.21, market capitalization USD 255.6 billion. Danaher (NYSE, USD): up 0.16 percent, price to earnings ratio 39.82, market capitalization USD 158.0 billion.

Price and the next date

The next company event is the October 28, 2026 third-quarter report. The euro quotation from Lang & Schwarz stood at EUR 14.91 on October 20, 2026 at 8:49 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Avantor stock.

Avantor stock facts

  • Company: Avantor, Inc.
  • ISIN: US05352A1007
  • Ticker: AVTR
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 20, 2026, 8:49 p.m. CEST: EUR 14.91
  • Market capitalization: USD 11.4 billion as of October 20, 2026
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

Market context: Market report S&P 500.

More news and analyses on Avantor stock

Disclaimer...
en | US05352A1007 | AVTR | boerse | 70377636 | bgmi